Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Key proteins and potential drugs for treating alopecia areata were identified.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Mesenchymal stem cells show promise for effective skin repair and regeneration.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Oral mucosa heals with minimal scarring, offering insights for scarless wound healing.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.